What Regeneron's Purchase Of 23andMe Means For Your Genetic Privacy

forbes.com/sites/larsdaniel/2025/05/21/what-regenerons-purchase-of-23andme-means-for-your-genetic-privacy

Regeneron Pharmaceuticals announced on Monday it will acquire bankrupt genomics firm 23andMe for $256 million through a bankruptcy auction, promising to maintain ethical standards in handling sensitive customer DNA information.
According to Reuters, the New York-based pharmaceutical…

This story appeared on forbes.com, 2025-05-21 20:24:19.
The Entire Business World on a Single Page. Free to Use →